# F2G: Biotechnology, Manchester, United Kingdom

> F2G: F2G discovers and develops novel drugs for the treatment of life-threatening fungal diseases. Based in Manchester, United Kingdom. Founded 1998.

Source: https://millionrounds.com/startup/f2g-2 (Millionrounds; every figure on the page links to its filing or article)

United Kingdom · [Biotechnology startup](https://millionrounds.com/companies)

# F2G

F2G discovers and develops novel drugs for the treatment of life-threatening fungal diseases.

Funding reported Last round: Private equity

Biotechnology Manchester, United Kingdom

Company summary

- **Founded:** 1998 28 years old
- **Team:** 11 11 to 50 people
- **Funding reported:** 283.3M as listed, currency not stated
- **Last round:** Private equity Aug 2022

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for F2G has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## What company datasets say F2G raised

Funding, as reported

Reported in all **283.3M** in the source's currency

Rounds **12**

Last round **Private equity**

Last round date **Aug 2022**

Investors listed **20**

## Funding filed with regulators

F2G filed one raise, $17M in all. Filings say how much was sold and to how many investors; they never name the investors.

- Jul 2021 **$17M** UK share allotment

## Founders and team

From F2G's own website: 6 on the team.

- **Francesco Maria Lavino** Chief Executive Officer
- **Mark Baglin** Chief Commercial Officer
- **Ralf Schmid** Chief Financial Officer
- **Camilla Soenderby** Non-Executive Director
- **Lesley Fitton** Executive Director, Clinical Operations
- **Tim Anderson** Non-Executive Director

## On 3 portfolio pages

Investors who name them

- [AMR Action Fund](https://millionrounds.com/fund/amr-action-fund)
- [Aisling Capital](https://millionrounds.com/fund/aisling-capital)
- [Brace Pharma](https://millionrounds.com/fund/brace-pharma-capital)

Each firm lists F2G on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## Biotechnology in United Kingdom

Startups like it

- [**COMPASS Pathways** Altrincham · founded 2016](https://millionrounds.com/startup/compass-pathways)
- [**Idrx** London · founded 2022](https://millionrounds.com/startup/idrx)
- [**Pepgen** Oxford · founded 2018](https://millionrounds.com/startup/pepgen)
- [**Beckley Psytech** Beckley · founded 2019](https://millionrounds.com/startup/beckley-psytech)
- [**Cambridge Epigenetix** Chesterford Research Park · founded 2012](https://millionrounds.com/startup/cambridge-epigenetix)
- [**Ascend Gene And Cell Therapies Ltd.** Altrincham · founded 2021](https://millionrounds.com/startup/ascend-gene-and-cell-therapies-ltd)
- [**Green Biologics** Abingdon · founded 2003](https://millionrounds.com/startup/green-biologics)
- [**Myricx Bio** London · founded 2019](https://millionrounds.com/startup/myricx-bio)

## Is this your company?

Add your raise, your deck and your story, and put F2G in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)